GenCrispr Cas9 Nuclease is the recombinant <i>Streptococcus pyogenes</i> Cas9 (wt) protein purified from E. coli and can be used for genome editing by inducing site-specific double stranded breaks in double stranded DNA. Cas9 protein forms a very stable ribonucleoprotein (RNP) complex with the guide RNA (gRNA) component of the CRISPR/Cas9 system. The RNP complex recognizes the target site by matching gRNA with the genomic DNA sequence and leads to DNA breaks within 3 bases from the NGG PAM (Protospacer Adjacent Motif). With GenCrispr Cas9 nuclease, customers can screen highly efficient...
GenCrispr Cas9 Nuclease is the recombinant <i>Streptococcus pyogenes</i> Cas9 (wt) protein purified from E. coli and can be used for genome editing by inducing site-specific double stranded breaks in double stranded DNA. Cas9 protein forms a very stable ribonucleoprotein (RNP) complex with the guide RNA (gRNA) component of the CRISPR/Cas9 system. The RNP complex recognizes the target site by matching gRNA with the genomic DNA sequence and leads to DNA breaks within 3 bases from the NGG PAM (Protospacer Adjacent Motif). With GenCrispr Cas9 nuclease, customers can screen highly efficient...
Shipping & Handling
Shipped In
DRY ICE
Safety & Storage
Storage Temperature
-20°C
Safety Statement
For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.
Regulatory & Compliance
Specifications
CLASS
Proteins, Enzymes
COUNTRY OF ORIGIN
China
*USAGE / SAFETY STATEMENT
For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.
SIZE
10μg (0.2mg/ml)
Questions & Answers (0)
Citations (0)
Shipping & Handling
Shipped In
DRY ICE
Safety & Storage
Storage Temperature
-20°C
Safety Statement
For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.
Regulatory & Compliance
We’re currently in BETA - Interested in joining? Let us know and we’ll get you set up with early access.
We’re currently in BETA - Interested in joining? Let us know and we’ll get you set up with early access.